Main > ONCOLOGY (**) > Breast Cancer>MET>HER2->gBRCA->* > TREAT.: > Co: UK. A. Olaparib Tablets 150 mg



Co: UK. A. Olaparib Tablets 150 mg's subsections
(*) USA Approval Date: 2018. 01.12
>Mutated>
Companion Diagnostics>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 12
Patent>UpDate: 2017. 09.19
TradeMark
TradeMark Web-Site

Co: UK. A. Olaparib Tablets 150 mg's products
This section has no products